• Weighing Options: Comparing Oral Anticoagulants for Patients at Various BMIs

  • Jul 19 2024
  • Duración: 17 m
  • Podcast

Weighing Options: Comparing Oral Anticoagulants for Patients at Various BMIs  Por  arte de portada

Weighing Options: Comparing Oral Anticoagulants for Patients at Various BMIs

  • Resumen

  • Direct oral anticoagulants (DOACs) are the standard of care for stroke prevention in most patients with nonvalvular atrial fibrillation (NVAF). Data on the safety and efficacy of DOACS in patients with obesity are limited and, at times, contradictory. What would you recommend for a patient with a BMI>40: warfarin, which requires periodic monitoring and dose adjustments, or a DOAC, which may not be as effective?

    Guest Authors: Taylor M. Benavides, PharmD, BCPS and Elizabeth B. Hearn, PharmD, BCACP

    Music by Good Talk

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Weighing Options: Comparing Oral Anticoagulants for Patients at Various BMIs

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.